ALKBH5 insufficiency protects against ferroptosis-driven cisplatin-induced renal cytotoxicity

Yu Zhu, Yanyan Jin, Xue He, JunYi Chen, Yao Zhang, JingJing Wang · 2024

Read ALKBH5 insufficiency protects against ferroptosis-driven cisplatin-induced renal cytotoxicity by Yu Zhu, Yanyan Jin, Xue He, JunYi Chen, Yao Zhang, JingJing Wang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11573822.txt.

Description

Yu Zhu and co-authors report in 2024 that blocking a protein called ALKBH5 can shield the kidney from a common cancer drug. The drug, cisplatin, often harms the kidney and can cause sudden kidney failure. The team links that harm to ferroptosis, a form of cell death driven by iron, and to the protein, which removes a chemical mark from RNA.

In mice and in cells, levels of the protein rose after the drug was given. Animals bred without it suffered less kidney harm, while animals with extra amounts fared worse. Drugs and gene therapy that target the protein also protected the kidney in animal tests. The work points to a fresh route for guarding kidneys during cancer care.

Catalog record

CREATORYu Zhu, Yanyan Jin, Xue He, JunYi Chen, Yao Zhang, JingJing Wang
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11573822

Browse the full library · About the Tower of Babel